Cartesian Therapeutics
RNAC
RNAC
68 hedge funds and large institutions have $119M invested in Cartesian Therapeutics in 2024 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 30 increasing their positions, 9 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
68
Holders Change
+4
Holders Change %
+6.25%
% of All Funds
0.91%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
15
Increased
30
Reduced
9
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
BlackRock
New York
|
$11.8M |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$7.69M |
3 |
MB
3
MPM BioImpact
Boston,
Massachusetts
|
$12.9M |
4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$3.96M |
5 |
6CM
5
683 Capital Management
New York
|
$2.24M |